Researchers at the University of California, San Diego (UCSD) School of Medicine have identified an over-active gene and the molecular events it triggers to cause acquired cases of pulmonary hypertension, a form of high blood pressure in the lungs that kills about one percent of the population each year.
The findings, published in the February 6, 2003 issue of the New England Journal of Medicine, offer the first specific molecular targets for development of new therapies.
"Although a small subset of patients benefit from surgery to remove blood clots from the lungs, currently the only treatment for most types of pulmonary hypertension is lung transplantation," said the studys senior author Patricia Thistlethwaite, M.D., Ph.D., an assistant professor in the UCSD Division of Cardiothoracic Surgery.
Sue Pondrom | EurekAlert!
eTRANSAFE – collaborative research project aimed at improving safety in drug development process
26.09.2017 | Fraunhofer-Gesellschaft
Beer can lift your spirits
26.09.2017 | Friedrich-Alexander-Universität Erlangen-Nürnberg
Controlling electronic current is essential to modern electronics, as data and signals are transferred by streams of electrons which are controlled at high speed. Demands on transmission speeds are also increasing as technology develops. Scientists from the Chair of Laser Physics and the Chair of Applied Physics at Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU) have succeeded in switching on a current with a desired direction in graphene using a single laser pulse within a femtosecond ¬¬ – a femtosecond corresponds to the millionth part of a billionth of a second. This is more than a thousand times faster compared to the most efficient transistors today.
Graphene is up to the job
A warming planet
19.09.2017 | Event News
12.09.2017 | Event News
06.09.2017 | Event News
26.09.2017 | Physics and Astronomy
26.09.2017 | Power and Electrical Engineering
26.09.2017 | Life Sciences